KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Return on Equity (2016 - 2025)

Historic Return on Equity for AbbVie (ABBV) over the last 13 years, with Q3 2025 value amounting to 1.72%.

  • AbbVie's Return on Equity fell 25200.0% to 1.72% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.72%, marking a year-over-year decrease of 25200.0%. This contributed to the annual value of 0.62% for FY2024, which is 2700.0% up from last year.
  • AbbVie's Return on Equity amounted to 1.72% in Q3 2025, which was down 25200.0% from 5.7% recorded in Q2 2025.
  • In the past 5 years, AbbVie's Return on Equity registered a high of 5.7% during Q2 2025, and its lowest value of 1.72% during Q3 2025.
  • Its 5-year average for Return on Equity is 0.86%, with a median of 0.71% in 2022.
  • Examining YoY changes over the last 5 years, AbbVie's Return on Equity showed a top increase of 49800bps in 2025 and a maximum decrease of -25200bps in 2025.
  • AbbVie's Return on Equity (Quarter) stood at 0.8% in 2021, then decreased by -11bps to 0.71% in 2022, then crashed by -39bps to 0.43% in 2023, then skyrocketed by 110bps to 0.91% in 2024, then crashed by -290bps to 1.72% in 2025.
  • Its Return on Equity was 1.72% in Q3 2025, compared to 5.7% in Q2 2025 and 1.74% in Q1 2025.